Tag: Pharmaceutical

Pyramid Labs
Global, United States

Pyramid Labs Appoints Dirk Lange as CEO and Announces a Doubling of Commercial Fill-Finish Capacity

COSTA MESA, Calif.–(BUSINESS WIRE)–Pyramid Labs, Inc. (“Pyramid” or the “Company”), a leader in drug product contract development and manufacturing with expertise in proteins, oligos, and peptides, announced today the appointment of Dirk Lange as Chief Executive Officer. Medhat Gorgy, who founded Pyramid in 1988 and has led the Company’s growth and evolution over its 36-year history, will continue to support the business as the Company’s … Continue reading Pyramid Labs Appoints Dirk Lange as CEO and Announces a Doubling of Commercial Fill-Finish Capacity

Impact Newswire
Vivani
Global, United States

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured in 2012 approval of Bydureon® (exenatide injection), the world’s first once-weekly GLP-1 receptor agonist, a class of drugs that now includes blockbusters Ozempic®, Trulicity®, and Wegovy® ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or … Continue reading Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Impact Newswire
Domain Therapeutics
Europe, Global

Domain Therapeutics Promotes Stephan Schann as Chief Scientific Officer (CSO)

February 27, 2024 07:10 AM Eastern Standard Time STRASBOURG, France & MONTREAL & BOSTON–(BUSINESS WIRE)–Domain Therapeutics (“Domain” or “the Company”), a clinical-stage global biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the expansion of the Company’s executive management team with the appointment of Stephan Schann as Chief Scientific Officer (CSO). Stephan will oversee the development of Domain’s proprietary … Continue reading Domain Therapeutics Promotes Stephan Schann as Chief Scientific Officer (CSO)

Impact Newswire
Experic
Global, United States

Experic Expands Global Clinical Trial Storage and Logistics Services to Europe

CRANBURY, N.J. &, DUBLIN–(BUSINESS WIRE)–Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced its new facility in Dublin, Ireland, to support global clinical trials. The opening of this depot will expand the Company’s global footprint, increase the efficiency of its worldwide clinical trial supply services, and facilitate future growth. When customers voiced their preference for … Continue reading Experic Expands Global Clinical Trial Storage and Logistics Services to Europe

Impact Newswire
Walgreens Boots Alliance
Global, United States

Walgreens Boots Alliance Names Lanesha Minnix Executive Vice President and Global Chief Legal Officer

Appointment completes CEO Tim Wentworth’s Executive Committee DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Lanesha Minnix the company’s executive vice president (EVP) and global chief legal officer. Minnix, most recently EVP, general counsel and corporate secretary for Ecolab, Inc., will assume her new role with WBA on April 15. “I look forward to working with Tim and the Executive Committee, as well … Continue reading Walgreens Boots Alliance Names Lanesha Minnix Executive Vice President and Global Chief Legal Officer

Impact Newswire
Amber Specialty Pharmacy
Global, United States

Jessica Ringena Named President of Amber Specialty Pharmacy

OMAHA, Neb.–(BUSINESS WIRE)–Amber Specialty Pharmacy announces the appointment of Jessica Ringena as its newest president. Ringena previously served as president of Vivid Clear Rx, a pharmacy benefit manager and subsidiary of Hy-Vee. Known for her strategic leadership in health care, technology, finance and innovation, Ringena will lead the specialty pharmacy in its mission to deliver personalized care to patients who experience chronic and complex conditions. … Continue reading Jessica Ringena Named President of Amber Specialty Pharmacy

Impact Newswire
Domain Therapeutics
Europe, Global

Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer

STRASBOURG, France & MONTREAL & BOSTON–(BUSINESS WIRE)–Domain Therapeutics (“Domain” or “the Company”), a clinical-stage global biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the appointment of Sean A. MacDonald as its Chief Business Officer (CBO) and member of the executive management team. In his new position, Sean will lead corporate strategy and business development bringing broad and deep … Continue reading Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer

Impact Newswire
Gilead Sciences
Global, United States

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Impact Newswire